Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: January 12, 2011
Last updated: March 30, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2015
  Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)